George Migausky
Directeur/Membre du Conseil chez IMMUNOVANT, INC.
Fortune : 3 M $ au 31/05/2024
Profil
George V.
Migausky is currently an Independent Director at REGENXBIO, Inc., a Director at Immunovant Sciences Ltd., an Independent Director at Immunovant, Inc., and a Trustee at Massachusetts Eye & Ear Infirmary, Inc. Previously, he served as an Independent Director at Abeona Therapeutics, Inc., Hyperion Catalysis International, Inc., and Dimension Therapeutics, Inc. He was also a Director at Rocket Pharmaceuticals, Inc., Health Sciences Acquisitions Corp., and Immunovant, Inc. In addition, he held the position of Chief Financial Officer & Executive Vice President at Dyax Corp.
from 2010 to 2016, and Chief Financial Officer & Vice President at BioVeris Corp.
from 1986 to 2007.
He has a Master's in Business Administration from Babson College and completed his undergraduate studies at Boston College in 1976.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
IMMUNOVANT INC
0,08% | 02/04/2024 | 121 063 ( 0,08% ) | 3 M $ | 31/05/2024 |
REGENXBIO, INC.
0,02% | 31/05/2024 | 11 286 ( 0,02% ) | 161 954 $ | 31/05/2024 |
Postes actifs de George Migausky
| Sociétés | Poste | Début |
|---|---|---|
| IMMUNOVANT, INC. | Directeur/Membre du Conseil | 18/12/2019 |
| REGENXBIO INC. | Directeur/Membre du Conseil | 03/09/2021 |
Immunovant Sciences Ltd.
 Immunovant Sciences Ltd. BiotechnologyHealth Technology Part of Roivant Sciences Ltd., Immunovant Sciences Ltd. develops restorative therapies for autoimmune diseases. The company is based in Hamilton, Bermuda. Immunovant Sciences was acquired by Health Sciences Acquisitions Corp. from Roivant Sciences Ltd. on December 19, 2019 for $863.06 million. | Directeur/Membre du Conseil | 01/03/2020 |
Massachusetts Eye & Ear Infirmary, Inc.
 Massachusetts Eye & Ear Infirmary, Inc. Medical/Nursing ServicesHealth Services Massachusetts Eye & Ear Infirmary operates as hospital that provides patient care for disorders of the eye, ear, nose, throat, head and neck. It offers ophthalmology and otolaryngology research services and is a teaching partner of Harvard Medical School. The firm’s programs and services include anesthesiology, ophthalmology, otolaryngology, radiology, Coolidge Clinic laboratory and libraries. The company was founded in 1824 and is headquartered in Boston, MA. | Directeur/Membre du Conseil | 01/01/2015 |
Anciens postes connus de George Migausky
| Sociétés | Poste | Fin |
|---|---|---|
| ABEONA THERAPEUTICS INC. | Directeur/Membre du Conseil | 27/09/2020 |
| DIMENSION THERAPEUTICS INC | Directeur/Membre du Conseil | 07/11/2017 |
| OCULAR THERAPEUTIX, INC. | Directeur Financier/CFO | 25/09/2017 |
| DYAX CORP. | Directeur Financier/CFO | 22/01/2016 |
Wellstat Management Co. LLC
 Wellstat Management Co. LLC Miscellaneous Commercial ServicesCommercial Services Wellstat Management Co. LLC provides management, legal, financial, human resources, information technology, business development, transactional, investment, licensing, and other services to the Wellstat group of companies. The company was founded by Samuel J. Wohlstadter in 2007 and is headquartered in Rockville, MD. | Directeur Financier/CFO | 01/01/2008 |
Formation de George Migausky
| Babson College | Masters Business Admin |
| Boston College | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 5 |
|---|---|
| OCULAR THERAPEUTIX, INC. | Health Technology |
| ROCKET PHARMACEUTICALS, INC. | Health Technology |
| IMMUNOVANT, INC. | Health Technology |
| ABEONA THERAPEUTICS INC. | Health Technology |
| REGENXBIO INC. | Health Technology |
| Entreprise privées | 11 |
|---|---|
IGEN International, Inc.
 IGEN International, Inc. Medical SpecialtiesHealth Technology IGEN International, Inc. develops and markets biological testing systems that incorporate its proprietary electrochemiluminescence technology for used in drug discovery, diagnostic products development as well as food and environmental safety testing. The company was founded in 1982 and is headquartered in Gaithersburg, MD. | Health Technology |
Deloitte & Touche
 Deloitte & Touche Miscellaneous Commercial ServicesCommercial Services Deloitte & Touche provides audit, enterprise risk management, and financial advisory services. The company delivers services in four professional areas: audit, tax, consulting, and financial advisory services. It provides its clients with global services such as entering foreign markets, raising funds, and investing in Mainland China. The company was founded in June, 2003 and is headquartered in Taipei, Taiwan. | Commercial Services |
Dyax Corp.
 Dyax Corp. Pharmaceuticals: MajorHealth Technology Dyax Corp. engages in discovery, development and commercialization of novel biotherapeutics. The company was founded by Henry E. Blair in 1989 and is headquartered in Burlington, MA. | Health Technology |
Wellstat Management Co. LLC
Wellstat Management Co. LLC Miscellaneous Commercial ServicesCommercial Services Wellstat Management Co. LLC provides management, legal, financial, human resources, information technology, business development, transactional, investment, licensing, and other services to the Wellstat group of companies. The company was founded by Samuel J. Wohlstadter in 2007 and is headquartered in Rockville, MD. | Commercial Services |
Dimension Therapeutics, Inc.
 Dimension Therapeutics, Inc. BiotechnologyHealth Technology Dimension Therapeutics, Inc. engages in the development of novel treatments for rare diseases. Its activities include discoveries and development of therapeutic products for people living with rare diseases associated wit the liver and caused by genetic mutations. The company was founded by Ben Auspitz in June 20, 2013 and is headquartered in Cambridge, MA. | Health Technology |
BioVeris Corp.
 BioVeris Corp. BiotechnologyHealth Technology BioVeris Corp. developed and manufactured diagnostic products. It operates as a global health care and biosecurity company that developing proprietary technologies in diagnostics and vaccinology. The firm specializes in electrochemiluminescence and immunochemistry. The company was founded in 2003 and is headquartered in Gaithersburg, MD. | Health Technology |
Health Sciences Acquisitions Corp.
 Health Sciences Acquisitions Corp. Financial ConglomeratesFinance Health Sciences Acquisitions Corp. operates as a blank check company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. It pursues prospective targets that are focused on healthcare innovation domiciled in North America or Europe that are developing assets in the biopharma and medical technology sectors. The company was founded on December 06, 2018 and is headquartered in New York, NY. | Finance |
Hyperion Catalysis International, Inc.
 Hyperion Catalysis International, Inc. Miscellaneous ManufacturingProducer Manufacturing Hyperion Catalysis International is a private company that specializes in the development and commercialization of carbon nanotubes. The company is based in Cambridge, MA. Hyperion Catalysis supplies Fibril nanotubes pre-mixed in a range of plastics for use in automotive and electronics applications. Founded in 1982, the company's flagship technology is a conductive, vapor grown, multi-walled carbon nanotube called Fibril™. | Producer Manufacturing |
Massachusetts Eye & Ear Infirmary, Inc.
Massachusetts Eye & Ear Infirmary, Inc. Medical/Nursing ServicesHealth Services Massachusetts Eye & Ear Infirmary operates as hospital that provides patient care for disorders of the eye, ear, nose, throat, head and neck. It offers ophthalmology and otolaryngology research services and is a teaching partner of Harvard Medical School. The firm’s programs and services include anesthesiology, ophthalmology, otolaryngology, radiology, Coolidge Clinic laboratory and libraries. The company was founded in 1824 and is headquartered in Boston, MA. | Health Services |
Immunovant, Inc. /Old/
 Immunovant, Inc. /Old/ BiotechnologyHealth Technology Immunovant, Inc. is a biopharmaceutical company, which engages in the development of therapies for autoimmune diseases. It focuses on its product pipeline, IMVT-1401, which is a human recombinant anti-neonatal Fc receptor monoclonal antibody for the treatment of IgG mediated diseases. The company is headquartered in New York, NY. | Health Technology |
Immunovant Sciences Ltd.
Immunovant Sciences Ltd. BiotechnologyHealth Technology Part of Roivant Sciences Ltd., Immunovant Sciences Ltd. develops restorative therapies for autoimmune diseases. The company is based in Hamilton, Bermuda. Immunovant Sciences was acquired by Health Sciences Acquisitions Corp. from Roivant Sciences Ltd. on December 19, 2019 for $863.06 million. | Health Technology |
